Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
25.34
+1.91 (8.15%)
Mar 31, 2025, 3:39 PM EDT - Market open

Company Description

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.

The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

This platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA).

It also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.

The company was founded in 2014 and is based in Kirkland, Washington.

Kestra Medical Technologies, Ltd.
Country United States
Founded 2014
IPO Date Mar 6, 2025
Industry Medical Devices
Sector Healthcare
Employees 300
CEO Brian Webster

Contact Details

Address:
3933 Lake Washington Blvd NE, Suite 200
Kirkland, Washington 98033
United States
Phone 425 279 8002
Website kestramedical.com

Stock Details

Ticker Symbol KMTS
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
IPO Price $17.00
CIK Code 0001877184
ISIN Number BMG524411052
SIC Code 3841

Key Executives

Name Position
Brian Webster President, Chief Executive Officer, and Director
Vaseem Mahboob Chief Financial Officer
Traci S. Umberger General Counsel, Chief Administrative Officer, and Director
Phillip D. Foshee, Jr. Senior Vice President of Research & Development
Debra Schotz Senior Vice President of Marketing
Jeffrey Laub Senior Vice President of Supply Chain Operations
Jeffrey Schwartz Director, Chairman of the Board of Directors
Raymond W. Cohen Director
Christopher Gordon Director
Mary Kay Ladone Director

Latest SEC Filings

Date Type Title
Mar 7, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 7, 2025 8-K Current Report
Mar 6, 2025 424B4 Prospectus
Mar 6, 2025 CERT Certification by an exchange approving securities for listing
Mar 6, 2025 8-A12B Registration of securities
Mar 5, 2025 EFFECT Notice of Effectiveness
Mar 5, 2025 S-1MEF Registration adding securities to prior Form S-1 registration
Mar 3, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 26, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 10, 2025 S-1 General form for registration of securities under the Securities Act of 1933